Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The present trial investigates the long-term safety, tolerability and efficacy of bosentan in patients with inoperable CTEPH.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Actelion
• Treatments: Bosentan

Criteria

Inclusion Criteria:

• Patients having completed the 16-week treatment period of protocol AC-052-366 (NCT00313222)

• Signed informed consent

Exclusion Criteria:

• Any major violation of protocol AC-052-366 (NCT00313222)

• Pregnancy or breast-feeding